| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Martin Madaus
Also a director
Interim CEO
Title from the Form 4 dated Oct 22, 2026
|
66 | Not stated | Not stated | Not reported | |
|
Lawrence Lin
EVP, CFO and Treasurer
Title from the Form 4 dated Nov 12, 2026
|
48 |
Since 2024
2 years
|
2024 | $3,909,752 | |
|
Ephraim Starr
Senior Vice President, General Counsel and Secretary
|
54 |
Since 2025
1 year
|
2025 | Not reported | |
|
Olga Pirogova
Senior Vice President and Chief Human Resources Officer
|
51 |
Since 2023
3 years
|
2023 | Not reported | |
|
Erik J. Bello
VP Chief Accounting Officer
Title from the Form 4 dated Sep 15, 2026
|
Not stated | Not stated | Not stated | Not reported | |
|
William “Trey” E. Martin III
President Multiomics
Title from the Form 4 dated Sep 14, 2026
|
Not stated | Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Dec 18, 2025 · updated by the 8-Ks of Feb 2, 2026, Aug 24, 2026, and Sep 17, 2026
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Dec 18, 2025 states there were none.
Read it in the proxyLoading...